• 
  Florent de Vathaire, Monia Zidane, Constance Xhaard, Vincent Souchard, Sylvie Chevillard, et al.. Assessment of Differentiated Thyroid Carcinomas in French Polynesia after Atmospheric Nuclear Tests Performed by France. JAMA Network Open, 2023, 6 (5), ⟨10.1001/jamanetworkopen.2023.11908⟩. ⟨hal-04106339⟩
• 
  Cyril Bourouh, Emilie Courty, Laure Rolland, Gianni Pasquetti, Xavier Gromada, et al.. The transcription factor E2F1 controls the GLP-1 receptor pathway in pancreatic β cells. Cell Reports, 2022, 40 (6), pp.111170. ⟨10.1016/j.celrep.2022.111170⟩. ⟨hal-03810743⟩
• 
  Fabian Garrido, Carl Mathis Wild, Udo Jeschke, Christian Dannecker, Doris Mayr, et al.. Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer. International Journal of Molecular Sciences, 2023, 24 (3), pp.2815. ⟨10.3390/ijms24032815⟩. ⟨hal-04109850⟩
• 
  Kanga Marius N’gatta, Habib Belaid, Joelle El Hayek, Edja Florentin Assanvo, Marilyn Kajdan, et al.. 3D printing of cellulose nanocrystals based composites to build robust biomimetic scaffolds for bone tissue engineering. Scientific Reports, 2022, 12 (1), pp.21244. ⟨10.1038/s41598-022-25652-x⟩. ⟨hal-04109785⟩
• 
  Kerstin Faravel, Marta Jarlier, Pierre Senesse, Marie-Eve Huteau, Chloé Janiszewski, et al.. Response to Somay et al. Letter to the Editor Regarding “Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy”. 2023, pp.153473542311673. ⟨10.1177/15347354231167367⟩. ⟨hal-04108142⟩
• 
  Angélique Bobrie, Océane Massol, Jeanne Ramos, Caroline Mollevi, Evelyne Lopez-Crapez, et al.. Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer. Cancers, 2022, 14 (19), pp.4829. ⟨10.3390/cancers14194829⟩. ⟨hal-04106210⟩
• 
  Yannick Dauwe, Lucile Mary, Fabiana Oliviero, Marina Grimaldi, Patrick Balaguer, et al.. Steatosis and Metabolic Disorders Associated with Synergistic Activation of the CAR/RXR Heterodimer by Pesticides. Cells, 2023, 12 (8), ⟨10.3390/cells12081201⟩. ⟨hal-04102903⟩
• 
  Emilia Rabia, Véronique Garambois, Christine Dhommée, Christel Larbouret, Laurie Lajoie, et al.. Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancer. Frontiers in Immunology, 2023, 14, ⟨10.3389/fimmu.2023.1168444⟩. ⟨hal-04102843⟩
• 
  F. Charles, A. Castet-Nicolas, C. Amouroux, J. Moreau, O. Werner, et al.. Evaluation of the impact of pharmaceutical trainings and tools on the proper use of medicines in pediatrics. Frontiers in Pharmacology, 2023, 14, pp.1143974. ⟨10.3389/fphar.2023.1143974⟩. ⟨hal-04097169⟩
• 
  Gregory Ninot, Estelle Guerdoux-Ninot, Fanny Leenhardt, François Carbonnel, Kerstin Faravel, et al.. Impact des Thérapies Complémentaires sur la Survie de Patients Atteints d’un Cancer Traités par Chimiothérapie Orale dans un Établissement Hospitalier Français Spécialisé en Oncologie : Étude Exploratoire. Oncologie, 2022, 24 (4), pp.605-612. ⟨10.32604/oncologie.2022.024558⟩. ⟨hal-04057055⟩
• 
  Jessica Andries, Wildriss Viranaicken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, et al.. The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMIRNATY vaccine (Pfizer/BioNTech). Scientific Reports, 2022, 12, pp.5999. ⟨10.1038/s41598-022-10057-7⟩. ⟨hal-04090801⟩
• 
  Yann‐alexandre Vano, Letuan Phan, Gwenaelle Gravis, Iphigénie Korakis, Friederike Schlürmann, et al.. Cabozantinib-nivolumab sequence in metastatic renal cell carcinoma: The CABIR study. International Journal of Cancer, 2022, 151 (8), pp.1335-1344. ⟨10.1002/ijc.34126⟩. ⟨hal-04085018⟩
• 
  Mathias Neron, Arnaud Guille, Lucie Allègre, Pierre-Emmanuel Colombo, Cristina Marinella Leaha, et al.. Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy. Journal of Personalized Medicine, 2022, 12 (5), pp.655. ⟨10.3390/jpm12050655⟩. ⟨hal-03765663⟩
• 
  M. Zarka, B. Tretarre, X. Rebillard, T. Murez, J.P. Daures, et al.. Le cancer des organes génitaux externes de l’homme dans le département de l’Hérault: résultats de 30 ans d’enregistrement du registre des tumeurs de l’Hérault (1987–2016). Progrès en Urologie, 2021, 31 (5), pp.282-292. ⟨10.1016/j.purol.2020.08.054⟩. ⟨hal-03660388⟩
• 
  Garazi Ruiz de Azua, Inès Vaz-Luis, Thomas Bovagnet, Antonio Di Meglio, Julie Havas, et al.. Perceived Discrimination at Work: examining social, health and work-related factors as determinants among breast cancer survivors. Evidence from the prospective CANTO cohort. Journal of Epidemiology and Community Health, 2022, 76 (11), pp.918-924. ⟨10.1007/s11764-022-01197-w⟩. ⟨hal-04067188⟩
• 
  Tarek Kammoun, Elodie Prévot, Chris Serrand, Romain Perolat, Hélène de Forges, et al.. Feasibility and Safety of Single-Probe Cryoablation with Liquid Nitrogen: An Initial Experience in 24 Various Tumor Lesions. Cancers, 2022, 14 (21), pp.5432. ⟨10.3390/cancers14215432⟩. ⟨hal-04061357⟩
• 
  Charlotte Donzé, Léa Rubira, Lore Santoro, Pierre Olivier Kotzki, Emmanuel Deshayes, et al.. Development and Implementation of a Professional Practices Evaluation during Radiopharmaceuticals Administration. Healthcare, 2022, 10 (11), pp.2247. ⟨10.3390/healthcare10112247⟩. ⟨hal-04061339⟩
• 
  Marguerite Kandel, Aurélie Bardet, Stéphane Dalle, Clara Allayous, Laurent Mortier, et al.. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Advanced Melanoma in Real Life in France. Current Oncology, 2022, 29 (12), pp.9255-9270. ⟨10.3390/curroncol29120725⟩. ⟨hal-04049403⟩
• 
  Juliette Legler, Daniel Zalko, Fabien Jourdan, Miriam Jacobs, Bernard Fromenty, et al.. The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds. inrae. 2020, pp.1-18/3480. ⟨hal-02638423v2⟩
• 
  François Noverraz, Baptiste Robin, Solène Passemard, Bénédicte Fauvel, Jessy Presumey, et al.. Novel trehalose-based excipients for stabilizing nebulized anti-SARS-CoV-2 antibody. International Journal of Pharmaceutics, 2023, 630, pp.122463. ⟨10.1016/j.ijpharm.2022.122463⟩. ⟨hal-03935985⟩

947

1 030